Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2026

Fair Value Disclosures [Abstract]

Schedule of Financial Instruments Measured at Fair Value

A summary of financial instruments measured at fair value was as follows (in thousands):

March 31, 2026	Level 1		Level 2		Level 3		Total
Cash equivalents
Money market funds	$	24,304	$	—	$	—	$	24,304
Certificates of deposit	1,094		—		—		1,094
Endospan Loans	—		—		20,402		20,402
Total assets	$	25,398	$	—	$	20,402	$	45,800
Liabilities
Current portion of contingent consideration	$	—	$	—	$	21,490	$	21,490
Non-current contingent consideration	—		—		40,830		40,830
Total liabilities	$	—	$	—	$	62,320	$	62,320

December 31, 2025	Level 1		Level 2		Level 3		Total
Cash equivalents
Money market funds	$	20,725	$	—	$	—	$	20,725
Certificates of deposit	1,080		—		—		1,080
Endospan Loans	—		—		19,872		19,872
Total assets	$	21,805	$	—	$	19,872	$	41,677
Liabilities
Current portion of contingent consideration	$	—	$	—	$	20,690	$	20,690
Non-current contingent consideration	—		—		39,890		39,890
Total liabilities	$	—	$	—	$	60,580	$	60,580

Schedule of Reconciliation of Changes in Fair Value of Level 3 Liabilities

Changes in fair value of Level 3 assets and liabilities are listed in the tables below (in thousands):

	Contingent Consideration
Balance as of December 31, 2025	$	60,580
Change in valuation	1,740
Balance as of March 31, 2026	$	62,320

	Endospan Loans
Balance as of December 31, 2025	$	19,872
Change in valuation	530
Balance as of March 31, 2026	$	20,402